XXXX after epidural @entity134 injection: Case report.

@entity1 @entity13959 @entity1971 @entity809 @entity134 @entity1745 @entity1188 @entity158 @entity1566 @entity451 @entity912
BACKGROUND: Given the risk of @entity912 associated with cervical transforaminal injection, is it time to reconsider transforaminal injections of the lumbar spine? Arguments for discontinuing lumbar injections have been discussed in the anesthesia literature, raising concern about the risks of epidural @entity134 injections (ESIs). METHODS: In a 47-year-old @entity1 , @entity451 of the lower extremities developed, specifically @entity1745 , after he underwent an @entity13959 for recurrent @entity158 . Correct needle placement was verified with epidurography. Immediately after the injection, the @entity1 felt his legs "going dead"; @entity451 of the lower extremities was noted. RESULTS: An initial magnetic resonance imaging study performed after the @entity1 was transferred to the emergency department was unremarkable. However, a later neurosurgical evaluation showed @entity1745 , and a second magnetic resonance imaging study showed the @entity1188 . We conducted a search of the PubMed database of articles from 2002 to 2011 containing the following keywords: complications, lumbar epidural @entity134 injection(s), @entity1971 , @entity1188 , @entity1188 , @entity1566 , @entity912 , paresis, @entity912 , @entity809 , and anesthesia. CONCLUSIONS: Summarizing this case and 5 similar cases, we weigh the potential benefits and risks of @entity13959 . Although one can safely assume that this severe, devastating complication is rare, we speculate that its true incidence remains unknown, possibly because of medicolegal implications. We believe that the rarity of this complication should not preclude the continued use of transforaminal @entity13959 ; rather, it should be emphasized for discussion with @entity1 during the consent process.
